Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 132.94M P/E - EPS this Y 12.40% Ern Qtrly Grth -
Income -78.63M Forward P/E -1.67 EPS next Y 7.30% 50D Avg Chg -47.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -58.00%
Dividend N/A Price/Book 0.81 EPS next 5Y - 52W High Chg -72.00%
Recommedations 1.20 Quick Ratio 6.30 Shares Outstanding 32.35M 52W Low Chg 29.00%
Insider Own 0.05% ROA -29.39% Shares Float 16.89M Beta -
Inst Own 76.67% ROE -54.59% Shares Shorted/Prior 260.40K/333.18K Price 5.59
Gross Margin - Profit Margin - Avg. Volume 65,759 Target Price 21.60
Oper. Margin - Earnings Date - Volume 118,668 Change -5.89%
About PepGen Inc.

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts.

PepGen Inc. News
03/13/24 PepGen to Participate in Upcoming Investor Conferences
03/13/24 PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
03/12/24 Can PepGen, Inc. (PEPG) Climb 48.62% to Reach the Level Wall Street Analysts Expect?
03/11/24 PepGen, Inc. (PEPG) Upgraded to Buy: What Does It Mean for the Stock?
03/06/24 PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments
03/04/24 PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
02/20/24 PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1
02/07/24 PepGen Announces Pricing of $80.1 Million Underwritten Offering of Common Stock
01/17/24 Mary Beth DeLena Joins PepGen as General Counsel and Secretary
01/12/24 Institutions own 24% of PepGen Inc. (NASDAQ:PEPG) shares but private equity firms control 54% of the company
01/08/24 PepGen Announces First Patient Dosed in CONNECT1-EDO51 Phase 2 Clinical Trial of PGN-EDO51 for Duchenne Muscular Dystrophy Patients Amenable to Exon 51 Skipping
12/18/23 PepGen Announces First Patient Dosed in Phase 1 FREEDOM-DM1 Clinical Trial of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1)
12/02/23 We Think PepGen (NASDAQ:PEPG) Needs To Drive Business Growth Carefully
11/15/23 PepGen Announces Appointment of Howard Mayer, M.D. to Board of Directors
11/08/23 PepGen Reports Third Quarter 2023 Financial Results and Recent Corporate Developments
10/12/23 PepGen Inc. Announces FDA has Lifted the Clinical Hold on its Investigational New Drug Application for FREEDOM-DM1 Phase 1 Study of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1)
09/27/23 PepGen Announces Upcoming Presentations at the 28th Annual Congress of the World Muscle Society and the World Congress of Neurology
09/06/23 PepGen Inc. Announces Clearance of CTA by Health Canada to Begin the FREEDOM-DM1 Phase 1 Study of PGN-EDODM1 in Patients with Myotonic Dystrophy Type 1
09/06/23 PepGen Inc. Presents PGN-EDODM1 Preclinical Data Supporting the Company’s Enhanced Delivery Oligonucleotide Platform and PGN-EDODM1 Program at Two Medical Conferences
09/01/23 PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference
PEPG Chatroom

User Image Stocks4thought Posted - 1 week ago

$PEPG No f-in pep talk needed $20 shortly................ot $LVTX $MAIA $SLNO $VYGR 12/04/2023 11:12:01 Bought 3000 PEPG @ 5.9379 -17,813.70

User Image Stock_Titan Posted - 2 weeks ago

$PEPG PepGen to Participate in Upcoming Investor Conferences https://www.stocktitan.net/news/PEPG/pep-gen-to-participate-in-upcoming-investor-kbcwdwu7lseu.html

User Image briefingcom Posted - 2 weeks ago

$PEPG: PepGen announces that the U.S. FDA granted both orphan drug and rare pediatric disease designations for PGN-EDO51 https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240313071702PEPG&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image OutTheCloset Posted - 2 weeks ago

$PEPG this could be what they needed to see 25

User Image Stock_Titan Posted - 2 weeks ago

$PEPG PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy https://www.stocktitan.net/news/PEPG/pep-gen-receives-u-s-fda-orphan-drug-and-rare-pediatric-disease-6w0cnwekjuhp.html

User Image cklee88 Posted - 3 weeks ago

$RNA $DYN $PEPG similar pipelines, 4x in 4 months, seriously overbought...

User Image OutTheCloset Posted - 3 weeks ago

$PEPG profit taking from offering

User Image Ruckus27 Posted - 3 weeks ago

$PEPG Damn..Why the dump?

User Image Stock_Titan Posted - 3 weeks ago

$PEPG PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments https://www.stocktitan.net/news/PEPG/pep-gen-reports-fourth-quarter-and-full-year-2023-financial-results-3u8pb4upc25q.html

User Image Stocks4thought Posted - 3 weeks ago

$STOK Last time we will see -C these prices- $8 then just as $PEPG did doubler...................ot $CRDF $MRKR $SLNO

User Image Stocks4thought Posted - 3 weeks ago

$STOK Once it pops into $8 we will get $9...............just like $PEPG at $8 awhile ago. 12/01/2023 10:26:08 Bought 2000 PEPG @ 4.9999 -9,999.80

User Image cklee88 Posted - 3 weeks ago

$RNA $dyn $pepg all with similar pipeline, boosted 4x simply to raise fund...too much overvalued for such a relatively small market.

User Image hspz Posted - 3 weeks ago

$PEPG

User Image Stocks4thought Posted - 3 weeks ago

$PEPG $20 this week or $CRDF $SLNO $QNCX $VINC

User Image Stocks4thought Posted - 3 weeks ago

$PEPG $18th birthday approaching.

User Image briefingcom Posted - 3 weeks ago

$PEPG: PepGen announces that the UK Medicines & Healthcare products Regulatory Agency has authorized its Clinical Trial Application to initiate the CONNECT2-EDO51 Phase 2 clinical trial of PGN-EDO51 in patients with Duchenne muscular dystrophy amenable to an exon 51-skipping approach. https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240304071916PEPG&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image Ninja_Tradez Posted - 3 weeks ago

📢 $PEPG - PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy https://newsfilter.io/a/4316492dbfbae775887f32cd5f50b7b9

User Image Stock_Titan Posted - 3 weeks ago

$PEPG PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy https://www.stocktitan.net/news/PEPG/pep-gen-announces-clearance-of-cta-by-uk-medicines-healthcare-dcfetg4v145y.html

User Image GoddessWen Posted - 3 weeks ago

$PEPG the next $IOVA ? 🚨 early bird alert 🚨 the early bird gets the worm. Next gen of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1. Good analyst valuation, large insider buys, phase 2 read out in mid-2024 $SLDB $CPRX $SRPT

User Image GoddessWen Posted - 3 weeks ago

$PEPG on my watchlist

User Image cklee88 Posted - 3 weeks ago

$RNA all similar tickers up about 4x...see $DYN $PEPG ... Top mgt starts unloading...see form144 and form 4.

User Image Stocks4thought Posted - 02/29/24

$PEPG My apologies $20 tmrw.

User Image Stu512 Posted - 02/29/24

$PASG $PEPG Little late with the info ! @Stocks4thought !!

User Image Stocks4thought Posted - 02/29/24

$PEPG $20 today

User Image Stocks4thought Posted - 02/29/24

$PEPG There you have it news at 11- its that easy folks. ot $PASG $CRDM 12/01/2023 10:26:08 Bought 2000 PEPG @ 4.9999 -9,999.80

User Image OutTheCloset Posted - 1 month ago

$PEPG RA is going to want to cash out much higher than this imo

User Image Stocks4thought Posted - 1 month ago

$PEPG We try and keep our promises $GANX $VKTX $INDP wild card!

User Image Stocks4thought Posted - 1 month ago

$PEPG buck stops here otr $GANX $AQST $SLNO

User Image OutTheCloset Posted - 1 month ago

$PEPG flagapalooza for next leg up

User Image Stocks4thought Posted - 1 month ago

$PEPG Magic dollar day general$ ot $QNCX $VYGR $STOK

Analyst Ratings
Wedbush Outperform Mar 7, 24
Wedbush Outperform Jan 30, 24
HC Wainwright & Co. Buy Sep 7, 23
HC Wainwright & Co. Buy Aug 9, 23
Stifel Buy Jun 14, 23
Wedbush Outperform Jun 14, 23
Wedbush Outperform May 31, 23
HC Wainwright & Co. Buy May 12, 23
HC Wainwright & Co. Buy Apr 3, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
McArthur James G President and CEO President and CEO Nov 30 Buy 4.165 1,694 7,056 1,694 12/05/23
McArthur James G President and CEO President and CEO Jun 08 Sell 16.04 2,381 38,191 06/09/23
McArthur James G President and CEO President and CEO Jun 08 Option 2.71 2,381 6,453 2,381 06/09/23
Goyal Jaya EVP, Res. & Preclin... EVP, Res. & Preclin. Dev. Mar 24 Sell 20 392 7,840 03/28/23
Goyal Jaya EVP, Res. & Preclin... EVP, Res. & Preclin. Dev. Mar 24 Option 10.88 392 4,265 392 03/28/23
Goyal Jaya EVP, Res. & Preclin... EVP, Res. & Preclin. Dev. Feb 06 Sell 17.07 6,000 102,420 02/08/23
Goyal Jaya EVP, Res. & Preclin... EVP, Res. & Preclin. Dev. Feb 06 Option 10.88 6,000 65,280 644 02/08/23
KEATING LAURIE Director Director May 06 Buy 12.00 4,166 49,992 4,166 01/19/23